Advertisement
Organisation › Details
Cytiva (Global Life Sciences Solutions, formerly GE Biopharma business of GE Life Sciences)
Cytiva is a global life sciences leader that works with academic and translational researchers, developers and manufacturers of biotherapeutics, cell and gene therapies, and new technologies such as mRNA, to enable the delivery of transformative medicines. Cytiva is a trusted expert with nearly 10 000 associates in more than 40 countries dedicated to customers' speed, flexibility, capacity and efficiency in drug discovery, research, and manufacturing. *
Start | 2020-03-31 renamed | |
Group | Danaher (Group) | |
Predecessor | GE Biopharma | |
Industry | LIFE SCIENCES | |
Industry 2 | bioreactor | |
Region | Little Chalfont, Buckinghamshire | |
Country | United Kingdom (GB) | |
Street | Amersham Place | |
City | HP7 9NA Little Chalfont | |
Address record changed: 2021-06-08 | ||
Basic data | Employees | G: 5,001 to 10,000 (2022-10-06) |
Currency | USD | |
Annual sales | 3,200,000,000 (sales, expected (2019) 2019-12-31) | |
* Document for »About Section«: Cytiva. (10/6/22). "Press Release: Cytiva Strengthens Cell Line Development with Cevec Acquisition". | ||
Record changed: 2023-07-10 |
Advertisement
More documents for Danaher (Group)
- [1] Danaher Corporation. (10/31/23). "Press Release: Danaher Appoints Christopher Riley to Executive Vice President for Biotechnology". Washington D.C.....
- [2] Danaher Corporation. (8/28/23). "Press Release: Danaher to Acquire Abcam". Washington, DC....
- [3] Molecular Devices, LLC. (2/7/23). "Press Release: Molecular Devices Partners with Seed Biosciences to Exclusively Offer DispenCell Single-Cell Dispenser, Expanding Leadership in Cell Line Development". San José, CA....
- [4] Refeyn Ltd.. (1/23/23). "Press Release: Refeyn Appoints Interim CEO"....
- [5] Molecular Devices, LLC. (1/4/23). "Press Release: Molecular Devices and Advanced Solutions Life Sciences Collaborate to Develop 3D Biology Automation Technologies for Drug Discovery". San José, CA....
- [6] Molecular Devices, LLC. (12/6/22). "Press Release: Molecular Devices Adds Proprietary Patient-derived Organoid Technology with Acquisition of Cellesce". San José, CA & Cardiff....
- [7] faCelliate GmbH. (11/30/22). "Press Release: faCellitate Appoints Christoph Petry, Ph.D. to Become Managing Director and CEO". Mannheim....
- [8] Ubiquigent Ltd.. (11/7/22). "Press Release: Ubiquigent Appoints Dr Hozefa Amijee as Head of Business Development". Dundee....
- [9] Cytiva. (10/6/22). "Press Release: Cytiva Strengthens Cell Line Development with Cevec Acquisition"....
- [10] Beckman Coulter Life Sciences. (9/13/22). "Press Release: ValitaCell Joins Beckman Coulter Life Sciences". Indianapolis, IN & Dublin....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Advertisement
» top